Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065

被引：14
|
作者：
Boger, DL
Stauffer, F
Hedrick, MP
机构：
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S0960-894X(01)00372-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of CBI analogues of the duocarmycins and CC-1065 exploring substituent effects within the first indole DNA binding subunit are detailed. Substitution at the indole C5 position led to cytotoxic potency enhancements that are greater than or equal to 1000-fold, providing simplified analogues containing a single DNA binding subunit that are more potent (IC50 = 2-3 pM) than CBI-TMI, duocarmycin SA, or CC-1065. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2021 / 2024
页数：4
相关论文
共 50 条
  • [31] Parallel synthesis and evaluation of 132 (+)-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of CC-1065 and the duocarmycins defining the contribution of the DNA-binding domain
    Boger, DL
    Schmitt, HW
    Fink, BE
    Hedrick, MP
    JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (20): : 6654 - 6661
  • [32] Molecular modeling study of binding between DNA and CC-1065 analogue
    Sun, GY
    Nicklaus, MC
    Simmons, DP
    Lai, LY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1342 - U1342
  • [33] PRELIMINARY TOXICITY STUDIES WITH THE DNA-BINDING ANTIBIOTIC, CC-1065
    MCGOVREN, JP
    CLARKE, GL
    PRATT, EA
    DEKONING, TF
    JOURNAL OF ANTIBIOTICS, 1984, 37 (01): : 63 - 70
  • [34] EVALUATION OF DNA-BINDING CHARACTERISTICS OF SOME CC-1065 ANALOGS
    SWENSON, DH
    PETZOLD, GL
    WILLIAMS, MG
    LI, LH
    PRAIRIE, MD
    KRUEGER, WC
    CHEMICO-BIOLOGICAL INTERACTIONS, 1988, 67 (3-4) : 199 - 213
  • [35] A novel class of in vivo active anticancer agents:: Achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065
    Sato, A
    McNulty, LA
    Cox, K
    Kim, S
    Scott, A
    Daniell, K
    Summerville, K
    Price, C
    Hudson, S
    Kiakos, K
    Hartley, JA
    Asao, T
    Lee, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (11) : 3903 - 3918
  • [36] DEMONSTRATION OF A PRONOUNCED EFFECT OF NONCOVALENT BINDING SELECTIVITY ON THE (+)-CC-1065 DNA ALKYLATION AND IDENTIFICATION OF THE PHARMACOPHORE OF THE ALKYLATION SUBUNIT
    BOGER, DL
    ZARRINMAYEH, H
    MUNK, SA
    KITOS, PA
    SUNTORNWAT, O
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) : 1431 - 1435
  • [37] SYNTHESIS OF CBI-PDE-I-DIMER, THE BENZANNELATED ANALOG OF CC-1065
    ARISTOFF, PA
    JOHNSON, PD
    JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (23): : 6234 - 6239
  • [38] CELL-CYCLE EFFECTS OF CC-1065
    BHUYAN, BK
    CRAMPTON, SL
    ADAMS, EG
    CANCER RESEARCH, 1983, 43 (09) : 4227 - 4232
  • [39] Synthesis of new water-soluble DNA-binding subunits for analogues of the cytotoxic antibiotic CC-1065 and their prodrugs
    Tietze, Lutz F.
    Major, Felix
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2006, 2006 (10) : 2314 - 2321
  • [40] CC-1065 analogues bearing different DNA-binding subunits: Synthesis, antitumor activity, and preliminary toxicity study
    Wang, YQ
    Li, LF
    Ye, WQ
    Tian, ZM
    Jiang, W
    Wang, H
    Wright, SC
    Larrick, JW
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) : 634 - 637
12345